Literature DB >> 19887856

Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?

E P de Jong1, E Lopriore, A C T M Vossen, S J Steggerda, A B Te Pas, A C M Kroes, F J Walther.   

Abstract

BACKGROUND: Congenital infections are associated with a wide spectrum of clinical symptoms, including lenticulostriate vasculopathy (LSV).
OBJECTIVE: To determine the relationship between LSV and congenital infections, as diagnosed by TORCH serology and viral culture for cytomegalovirus (CMV).
METHODS: All neonates with LSV admitted to our neonatal intensive-care unit from 2004 to 2008 were included in the study. Results of maternal and neonatal TORCH testing were evaluated.
RESULTS: During the study period, cranial ultrasound scans were performed in 2,088 neonates. LSV was detected in 80 (4%) neonates. Maternal and/or neonatal serological TORCH tests were performed in 73% (58/80) of cases. None of the mothers or infants (0 of 58) had positive IgM titres for Toxoplasma, rubella, CMV or herpes simplex virus. Additional urine culture for CMV was performed in 38 neonates. None of the infants (0 of 38) had a positive CMV urine culture test.
CONCLUSIONS: Routinely applied efforts to diagnose congenital infections in cases presenting with LSV have a poor yield. Routine TORCH screening in neonates with LSV cases should only be regarded as mandatory once well-designed studies demonstrate a clear diagnostic benefit. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19887856     DOI: 10.1159/000255166

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  2 in total

1.  Risk factors and associated diseases among preterm infants with isolated lenticulostriate vasculopathy.

Authors:  A Maayan-Metzger; L Leibovitch; I Schushan-Eisen; M Soudack; T Strauss
Journal:  J Perinatol       Date:  2016-04-21       Impact factor: 2.521

2.  Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection.

Authors:  Joppe Nijman; Femke S Mandemaker; Malgorzata A Verboon-Maciolek; Susan C Aitken; Anton M van Loon; Linda S de Vries; Rob Schuurman
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.